137 related articles for article (PubMed ID: 10484465)
21. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
Idell S
Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
[TBL] [Abstract][Full Text] [Related]
22. Differential expression of the urokinase receptor in fibroblasts from normal and fibrotic human lungs.
Shetty S; Kumar A; Johnson AR; Pueblitz S; Holiday D; Raghu G; Idell S
Am J Respir Cell Mol Biol; 1996 Jul; 15(1):78-87. PubMed ID: 8679225
[TBL] [Abstract][Full Text] [Related]
23. Urokinase-mediated posttranscriptional regulation of urokinase-receptor expression in non small cell lung carcinoma.
Montuori N; Mattiello A; Mancini A; Taglialatela P; Caputi M; Rossi G; Ragno P
Int J Cancer; 2003 Jun; 105(3):353-60. PubMed ID: 12704669
[TBL] [Abstract][Full Text] [Related]
24. Detection of the receptor for the human urokinase-type plasminogen activator using fluoresceinated uPA.
Ciccocioppo R; Capri MG; Alberti S
J Histochem Cytochem; 1997 Sep; 45(9):1307-13. PubMed ID: 9283618
[TBL] [Abstract][Full Text] [Related]
25. cDNA transfection of amino-terminal fragment of urokinase efficiently inhibits cancer cell invasion and metastasis.
Zhu F; Jia S; Xing G; Gao L; Zhang L; He F
DNA Cell Biol; 2001 May; 20(5):297-305. PubMed ID: 11410166
[TBL] [Abstract][Full Text] [Related]
26. In situ gene expression of urokinase-type plasminogen activator and its receptor in transitional cell carcinoma of the human bladder.
Bhuvarahamurthy V; Schroeder J; Denkert C; Kristiansen G; Schnorr D; Loening SA; Jung K; Staack A
Oncol Rep; 2004 Oct; 12(4):909-13. PubMed ID: 15375521
[TBL] [Abstract][Full Text] [Related]
27. Expression and function of the urokinase type plasminogen activator during mouse hemochorial placental development.
Teesalu T; Blasi F; Talarico D
Dev Dyn; 1998 Sep; 213(1):27-38. PubMed ID: 9733098
[TBL] [Abstract][Full Text] [Related]
28. The fibrinolytic system and the regulation of lung epithelial cell proteolysis, signaling, and cellular viability.
Shetty S; Padijnayayveetil J; Tucker T; Stankowska D; Idell S
Am J Physiol Lung Cell Mol Physiol; 2008 Dec; 295(6):L967-75. PubMed ID: 18836029
[TBL] [Abstract][Full Text] [Related]
29. Regulation and interactions in the activation of cell-associated plasminogen.
Myöhänen H; Vaheri A
Cell Mol Life Sci; 2004 Nov; 61(22):2840-58. PubMed ID: 15558213
[TBL] [Abstract][Full Text] [Related]
30. Urokinase-type plasminogen activator and its receptor synergize to promote pathogenic proteolysis.
Zhou HM; Nichols A; Meda P; Vassalli JD
EMBO J; 2000 Sep; 19(17):4817-26. PubMed ID: 10970872
[TBL] [Abstract][Full Text] [Related]
31. Urokinase/urokinase receptor system: internalization/degradation of urokinase-serpin complexes: mechanism and regulation.
Conese M; Blasi F
Biol Chem Hoppe Seyler; 1995 Mar; 376(3):143-55. PubMed ID: 7612191
[TBL] [Abstract][Full Text] [Related]
32. Urokinase induces expression of its own receptor in Beas2B lung epithelial cells.
Shetty S; Idell S
J Biol Chem; 2001 Jul; 276(27):24549-56. PubMed ID: 11342540
[TBL] [Abstract][Full Text] [Related]
33. Urokinase plasminogen activator amino-terminal peptides inhibit development of the rat ventral prostate.
Elfman F; Bok R; Conn M; Shuman M; Cunha G
Differentiation; 2001 Dec; 69(2-3):108-20. PubMed ID: 11798065
[TBL] [Abstract][Full Text] [Related]
34. Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors.
Yoshizawa K; Nozaki S; Kitahara H; Kato K; Noguchi N; Kawashiri S; Yamamoto E
Oncol Rep; 2011 Dec; 26(6):1555-60. PubMed ID: 21833477
[TBL] [Abstract][Full Text] [Related]
35. Mac-1 (CD11b/CD18) and the urokinase receptor (CD87) form a functional unit on monocytic cells.
Simon DI; Rao NK; Xu H; Wei Y; Majdic O; Ronne E; Kobzik L; Chapman HA
Blood; 1996 Oct; 88(8):3185-94. PubMed ID: 8874219
[TBL] [Abstract][Full Text] [Related]
36. Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity.
Czekay RP; Kuemmel TA; Orlando RA; Farquhar MG
Mol Biol Cell; 2001 May; 12(5):1467-79. PubMed ID: 11359936
[TBL] [Abstract][Full Text] [Related]
37. Cell surface-bound urokinase-type plasminogen activator facilitates infiltration of freshly isolated granulocytes into fibrin matrix.
Herijgers N; Vettel U; Schaefer B; Spring H; Todd RF; Kramer MD
Immunobiology; 1995 Nov; 194(4-5):363-75. PubMed ID: 8749230
[TBL] [Abstract][Full Text] [Related]
38. Antigen-driven lymphocyte recruitment to the lung is diminished in the absence of urokinase-type plasminogen activator (uPA) receptor, but is independent of uPA.
Gyetko MR; Sud S; Sonstein J; Polak T; Sud A; Curtis JL
J Immunol; 2001 Nov; 167(10):5539-42. PubMed ID: 11698423
[TBL] [Abstract][Full Text] [Related]
39. Fibrin affinity of urokinase-type plasminogen activator. Evidence that Zn2+ mediates strong and specific interaction of single-chain urokinase with fibrin.
Husain SS
J Biol Chem; 1993 Apr; 268(12):8574-9. PubMed ID: 8473303
[TBL] [Abstract][Full Text] [Related]
40. Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-beta to TGF-beta.
Odekon LE; Blasi F; Rifkin DB
J Cell Physiol; 1994 Mar; 158(3):398-407. PubMed ID: 8126064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
